Lu, W.; Eapen, M.S.; Singhera, G.K.; Markos, J.; Haug, G.; Chia, C.; Larby, J.; Brake, S.J.; Westall, G.P.; Jaffar, J.;
et al. Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections. J. Clin. Med. 2022, 11, 777.
https://doi.org/10.3390/jcm11030777
AMA Style
Lu W, Eapen MS, Singhera GK, Markos J, Haug G, Chia C, Larby J, Brake SJ, Westall GP, Jaffar J,
et al. Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections. Journal of Clinical Medicine. 2022; 11(3):777.
https://doi.org/10.3390/jcm11030777
Chicago/Turabian Style
Lu, Wenying, Mathew Suji Eapen, Gurpreet Kaur Singhera, James Markos, Greg Haug, Collin Chia, Josie Larby, Samuel James Brake, Glen P. Westall, Jade Jaffar,
and et al. 2022. "Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections" Journal of Clinical Medicine 11, no. 3: 777.
https://doi.org/10.3390/jcm11030777
APA Style
Lu, W., Eapen, M. S., Singhera, G. K., Markos, J., Haug, G., Chia, C., Larby, J., Brake, S. J., Westall, G. P., Jaffar, J., Kalidhindi, R. S. R., Fonseka, N. D., Sathish, V., Hackett, T. L., & Sohal, S. S.
(2022). Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections. Journal of Clinical Medicine, 11(3), 777.
https://doi.org/10.3390/jcm11030777
